Efficacy of Ivermectin Treatment in Elderly Scabies Patients

• Tamura Nobuko

  Department of Dermatology, Yokosuka Hokubu Kyousai Hospital

• Ishii Norihisa

  Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases (NIID)

Bibliographic Information

Other Title

• 高齢者の疥癬に対するイベルメクチンの治療効果について
• コウレイシャ ノ カイセン ニ タイスル イベルメクチン ノ チリョウ コウカ ニ ツイテ

Abstract

We examined the efficacy and safety of ivermectin for the treatment of scabies in the elderly. Sixteen patients (average age ; 82.8 years) were treated with ivermectin (200 μg/kg) twice with an interval of one week. The patients were evaluated three weeks after the first treatment. Eleven of the 13 patients had no clinical or microscopic evidence of scabies. No abnormal laboratory findings were observed. As adverse events, mild and transient diarrhea and toxicoderma arose in two different patients. No recurrence was observed four months after the treatment. Taken together, our results indicate that ivermectin is effective and safe for the treatment of elderly scabies patients.

Journal

• The Japanese Journal of Dermatology

  The Japanese Journal of Dermatology 115 (14), 2405-2407, 2005

  Japanese Dermatological Association

Keywords

• scabies
• ivermectin
• treatment
• elderly patients
• efficacy

Details

• CRID: 1390001205740031360
• NII Article ID: 130004714753
• NII Article ID: 10018081112
• NII Book ID: AN00196602
• DOI: 10.14924/dermatol.115.2405
• ISSN: 13468146
• ISSN: 0021499X
• NDL BIB ID: 7789589
• Web Site: http://id.ndl.go.jp/bib/7789589
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I7789589
• Web Site: https://search.jamas.or.jp/link/ui/2006072018
• Text Lang: ja
• Data Source:
  • JaLC
  • NDL
  • CiNii Articles
  • Crossref
• Abstract License Flag: Disallowed